Immunosuppressive and trafficking properties of donor splenic and bone marrow dendritic cells

Infusion of donor dendritic cells (DC) has been shown to prolong allograft survival in a number of models. However, many regimens that utilize donor DC do not consistently produced tolerance or long-term allograft survival. We hypothesized that one factor limiting the therapeutic effect of donor DC...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Transplantation 2006-02, Vol.81 (3), p.455-462
Hauptverfasser: EMMANOUILIDIS, Nikos, ZHONG GUO, YING DONG, NEWTON-WEST, Marvin, ADAMS, Andrew B, HAN LEE, Eun D, JUN WANG, PEARSON, Thomas C, LARSEN, Christian P, NEWELL, Kenneth A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 462
container_issue 3
container_start_page 455
container_title Transplantation
container_volume 81
creator EMMANOUILIDIS, Nikos
ZHONG GUO
YING DONG
NEWTON-WEST, Marvin
ADAMS, Andrew B
HAN LEE, Eun D
JUN WANG
PEARSON, Thomas C
LARSEN, Christian P
NEWELL, Kenneth A
description Infusion of donor dendritic cells (DC) has been shown to prolong allograft survival in a number of models. However, many regimens that utilize donor DC do not consistently produced tolerance or long-term allograft survival. We hypothesized that one factor limiting the therapeutic effect of donor DC is their relative inability to traffic to recipient peripheral lymph nodes and inhibit the function of resident alloreactive T cells. Donor strain DC isolated from the spleens or bone marrow of Flt3L-treated mice were transferred intravenously into recipients at the time of skin grafting. Where indicated, recipients were treated with an anti-CD40L antibody and CTLA4-Ig. Infusion of donor DC together with costimulatory blockade promoted donor-specific prolongation of skin allograft survival in mice. Perhaps due to their more immature phenotype, bone marrow DC trafficked more effectively to the spleen, bone marrow, and thymus and were associated with significantly longer allograft survival than were splenic DC. Neither population of DC trafficked well to peripheral lymph nodes. Consistent with our hypothesis, splenic but not lymph node T cells from DC-treated recipients displayed donor-specific hyporesponsiveness in vitro. These data suggest that one factor contributing to rejection following treatment with donor DC plus costimulation blockade is the persistence of donor-reactive T cells within the recipient's secondary lymphoid structures. Strategies to improve DC trafficking to these structures may enhance their therapeutic effect.
doi_str_mv 10.1097/01.tp.0000195779.01491.4e
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67659038</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67659038</sourcerecordid><originalsourceid>FETCH-LOGICAL-c456t-24f03b5d11b5ea4d0f8e7acf5713fe5b1519368779c940e6019c12602250dcad3</originalsourceid><addsrcrecordid>eNqFkctu1TAQhi0EoofCK6CwgF3CTGzH8RJVXCpV6oYuK8txxsiQxMFOQH37uu2RzrKzmcV8c_nnZ-wDQoOg1WfAZlsbKIFaKqUbQKGxEfSCHVByUXfQw0t2ABBYI-fqjL3J-XfhJVfqNTvDTijVcnFgt5fzvC8x7-uaKOfwjyq7jNWWrPfB_QnLr2pNcaW0BcpV9NUYl5iqvE60BPfIDnGharYpxf_VSMuYwlYqjqYpv2WvvJ0yvTvmc3bz7evPix_11fX3y4svV7UTstvqVnjggxwRB0lWjOB7UtZ5qZB7kgNK1Lzri1KnBVBXZDtsO2hbCaOzIz9nn57mllv_7pQ3M4f8cIFdKO7ZdKqTGnj_LIgKdNsKKKB-Al2KOSfyZk2hiLwzCObBBANottWcTDCPJhhBpff9cck-zDSeOo9fL8DHI2Czs5NPdnEhnzgl215Kzu8BaSiRig</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17092240</pqid></control><display><type>article</type><title>Immunosuppressive and trafficking properties of donor splenic and bone marrow dendritic cells</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>EMMANOUILIDIS, Nikos ; ZHONG GUO ; YING DONG ; NEWTON-WEST, Marvin ; ADAMS, Andrew B ; HAN LEE, Eun D ; JUN WANG ; PEARSON, Thomas C ; LARSEN, Christian P ; NEWELL, Kenneth A</creator><creatorcontrib>EMMANOUILIDIS, Nikos ; ZHONG GUO ; YING DONG ; NEWTON-WEST, Marvin ; ADAMS, Andrew B ; HAN LEE, Eun D ; JUN WANG ; PEARSON, Thomas C ; LARSEN, Christian P ; NEWELL, Kenneth A</creatorcontrib><description>Infusion of donor dendritic cells (DC) has been shown to prolong allograft survival in a number of models. However, many regimens that utilize donor DC do not consistently produced tolerance or long-term allograft survival. We hypothesized that one factor limiting the therapeutic effect of donor DC is their relative inability to traffic to recipient peripheral lymph nodes and inhibit the function of resident alloreactive T cells. Donor strain DC isolated from the spleens or bone marrow of Flt3L-treated mice were transferred intravenously into recipients at the time of skin grafting. Where indicated, recipients were treated with an anti-CD40L antibody and CTLA4-Ig. Infusion of donor DC together with costimulatory blockade promoted donor-specific prolongation of skin allograft survival in mice. Perhaps due to their more immature phenotype, bone marrow DC trafficked more effectively to the spleen, bone marrow, and thymus and were associated with significantly longer allograft survival than were splenic DC. Neither population of DC trafficked well to peripheral lymph nodes. Consistent with our hypothesis, splenic but not lymph node T cells from DC-treated recipients displayed donor-specific hyporesponsiveness in vitro. These data suggest that one factor contributing to rejection following treatment with donor DC plus costimulation blockade is the persistence of donor-reactive T cells within the recipient's secondary lymphoid structures. Strategies to improve DC trafficking to these structures may enhance their therapeutic effect.</description><identifier>ISSN: 0041-1337</identifier><identifier>EISSN: 1534-6080</identifier><identifier>DOI: 10.1097/01.tp.0000195779.01491.4e</identifier><identifier>PMID: 16477234</identifier><identifier>CODEN: TRPLAU</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott</publisher><subject>Animals ; Biological and medical sciences ; Bone Marrow Cells - immunology ; Cell Movement - immunology ; Dendritic Cells - immunology ; Dendritic Cells - transplantation ; Fundamental and applied biological sciences. Psychology ; Fundamental immunology ; Graft Enhancement, Immunologic ; Graft Rejection - therapy ; Graft Survival - immunology ; Isoantigens - immunology ; Lymph Nodes - cytology ; Male ; Medical sciences ; Mice ; Mice, Inbred BALB C ; Mice, Inbred C57BL ; Skin Transplantation - immunology ; Spleen - cytology ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; T-Lymphocytes - immunology ; Tissue, organ and graft immunology ; Transplantation, Homologous</subject><ispartof>Transplantation, 2006-02, Vol.81 (3), p.455-462</ispartof><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c456t-24f03b5d11b5ea4d0f8e7acf5713fe5b1519368779c940e6019c12602250dcad3</citedby><cites>FETCH-LOGICAL-c456t-24f03b5d11b5ea4d0f8e7acf5713fe5b1519368779c940e6019c12602250dcad3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=17528553$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16477234$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>EMMANOUILIDIS, Nikos</creatorcontrib><creatorcontrib>ZHONG GUO</creatorcontrib><creatorcontrib>YING DONG</creatorcontrib><creatorcontrib>NEWTON-WEST, Marvin</creatorcontrib><creatorcontrib>ADAMS, Andrew B</creatorcontrib><creatorcontrib>HAN LEE, Eun D</creatorcontrib><creatorcontrib>JUN WANG</creatorcontrib><creatorcontrib>PEARSON, Thomas C</creatorcontrib><creatorcontrib>LARSEN, Christian P</creatorcontrib><creatorcontrib>NEWELL, Kenneth A</creatorcontrib><title>Immunosuppressive and trafficking properties of donor splenic and bone marrow dendritic cells</title><title>Transplantation</title><addtitle>Transplantation</addtitle><description>Infusion of donor dendritic cells (DC) has been shown to prolong allograft survival in a number of models. However, many regimens that utilize donor DC do not consistently produced tolerance or long-term allograft survival. We hypothesized that one factor limiting the therapeutic effect of donor DC is their relative inability to traffic to recipient peripheral lymph nodes and inhibit the function of resident alloreactive T cells. Donor strain DC isolated from the spleens or bone marrow of Flt3L-treated mice were transferred intravenously into recipients at the time of skin grafting. Where indicated, recipients were treated with an anti-CD40L antibody and CTLA4-Ig. Infusion of donor DC together with costimulatory blockade promoted donor-specific prolongation of skin allograft survival in mice. Perhaps due to their more immature phenotype, bone marrow DC trafficked more effectively to the spleen, bone marrow, and thymus and were associated with significantly longer allograft survival than were splenic DC. Neither population of DC trafficked well to peripheral lymph nodes. Consistent with our hypothesis, splenic but not lymph node T cells from DC-treated recipients displayed donor-specific hyporesponsiveness in vitro. These data suggest that one factor contributing to rejection following treatment with donor DC plus costimulation blockade is the persistence of donor-reactive T cells within the recipient's secondary lymphoid structures. Strategies to improve DC trafficking to these structures may enhance their therapeutic effect.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Bone Marrow Cells - immunology</subject><subject>Cell Movement - immunology</subject><subject>Dendritic Cells - immunology</subject><subject>Dendritic Cells - transplantation</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Fundamental immunology</subject><subject>Graft Enhancement, Immunologic</subject><subject>Graft Rejection - therapy</subject><subject>Graft Survival - immunology</subject><subject>Isoantigens - immunology</subject><subject>Lymph Nodes - cytology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Mice, Inbred C57BL</subject><subject>Skin Transplantation - immunology</subject><subject>Spleen - cytology</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>T-Lymphocytes - immunology</subject><subject>Tissue, organ and graft immunology</subject><subject>Transplantation, Homologous</subject><issn>0041-1337</issn><issn>1534-6080</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkctu1TAQhi0EoofCK6CwgF3CTGzH8RJVXCpV6oYuK8txxsiQxMFOQH37uu2RzrKzmcV8c_nnZ-wDQoOg1WfAZlsbKIFaKqUbQKGxEfSCHVByUXfQw0t2ABBYI-fqjL3J-XfhJVfqNTvDTijVcnFgt5fzvC8x7-uaKOfwjyq7jNWWrPfB_QnLr2pNcaW0BcpV9NUYl5iqvE60BPfIDnGharYpxf_VSMuYwlYqjqYpv2WvvJ0yvTvmc3bz7evPix_11fX3y4svV7UTstvqVnjggxwRB0lWjOB7UtZ5qZB7kgNK1Lzri1KnBVBXZDtsO2hbCaOzIz9nn57mllv_7pQ3M4f8cIFdKO7ZdKqTGnj_LIgKdNsKKKB-Al2KOSfyZk2hiLwzCObBBANottWcTDCPJhhBpff9cck-zDSeOo9fL8DHI2Czs5NPdnEhnzgl215Kzu8BaSiRig</recordid><startdate>20060215</startdate><enddate>20060215</enddate><creator>EMMANOUILIDIS, Nikos</creator><creator>ZHONG GUO</creator><creator>YING DONG</creator><creator>NEWTON-WEST, Marvin</creator><creator>ADAMS, Andrew B</creator><creator>HAN LEE, Eun D</creator><creator>JUN WANG</creator><creator>PEARSON, Thomas C</creator><creator>LARSEN, Christian P</creator><creator>NEWELL, Kenneth A</creator><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20060215</creationdate><title>Immunosuppressive and trafficking properties of donor splenic and bone marrow dendritic cells</title><author>EMMANOUILIDIS, Nikos ; ZHONG GUO ; YING DONG ; NEWTON-WEST, Marvin ; ADAMS, Andrew B ; HAN LEE, Eun D ; JUN WANG ; PEARSON, Thomas C ; LARSEN, Christian P ; NEWELL, Kenneth A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c456t-24f03b5d11b5ea4d0f8e7acf5713fe5b1519368779c940e6019c12602250dcad3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Bone Marrow Cells - immunology</topic><topic>Cell Movement - immunology</topic><topic>Dendritic Cells - immunology</topic><topic>Dendritic Cells - transplantation</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Fundamental immunology</topic><topic>Graft Enhancement, Immunologic</topic><topic>Graft Rejection - therapy</topic><topic>Graft Survival - immunology</topic><topic>Isoantigens - immunology</topic><topic>Lymph Nodes - cytology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Mice, Inbred C57BL</topic><topic>Skin Transplantation - immunology</topic><topic>Spleen - cytology</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>T-Lymphocytes - immunology</topic><topic>Tissue, organ and graft immunology</topic><topic>Transplantation, Homologous</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>EMMANOUILIDIS, Nikos</creatorcontrib><creatorcontrib>ZHONG GUO</creatorcontrib><creatorcontrib>YING DONG</creatorcontrib><creatorcontrib>NEWTON-WEST, Marvin</creatorcontrib><creatorcontrib>ADAMS, Andrew B</creatorcontrib><creatorcontrib>HAN LEE, Eun D</creatorcontrib><creatorcontrib>JUN WANG</creatorcontrib><creatorcontrib>PEARSON, Thomas C</creatorcontrib><creatorcontrib>LARSEN, Christian P</creatorcontrib><creatorcontrib>NEWELL, Kenneth A</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Transplantation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>EMMANOUILIDIS, Nikos</au><au>ZHONG GUO</au><au>YING DONG</au><au>NEWTON-WEST, Marvin</au><au>ADAMS, Andrew B</au><au>HAN LEE, Eun D</au><au>JUN WANG</au><au>PEARSON, Thomas C</au><au>LARSEN, Christian P</au><au>NEWELL, Kenneth A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immunosuppressive and trafficking properties of donor splenic and bone marrow dendritic cells</atitle><jtitle>Transplantation</jtitle><addtitle>Transplantation</addtitle><date>2006-02-15</date><risdate>2006</risdate><volume>81</volume><issue>3</issue><spage>455</spage><epage>462</epage><pages>455-462</pages><issn>0041-1337</issn><eissn>1534-6080</eissn><coden>TRPLAU</coden><abstract>Infusion of donor dendritic cells (DC) has been shown to prolong allograft survival in a number of models. However, many regimens that utilize donor DC do not consistently produced tolerance or long-term allograft survival. We hypothesized that one factor limiting the therapeutic effect of donor DC is their relative inability to traffic to recipient peripheral lymph nodes and inhibit the function of resident alloreactive T cells. Donor strain DC isolated from the spleens or bone marrow of Flt3L-treated mice were transferred intravenously into recipients at the time of skin grafting. Where indicated, recipients were treated with an anti-CD40L antibody and CTLA4-Ig. Infusion of donor DC together with costimulatory blockade promoted donor-specific prolongation of skin allograft survival in mice. Perhaps due to their more immature phenotype, bone marrow DC trafficked more effectively to the spleen, bone marrow, and thymus and were associated with significantly longer allograft survival than were splenic DC. Neither population of DC trafficked well to peripheral lymph nodes. Consistent with our hypothesis, splenic but not lymph node T cells from DC-treated recipients displayed donor-specific hyporesponsiveness in vitro. These data suggest that one factor contributing to rejection following treatment with donor DC plus costimulation blockade is the persistence of donor-reactive T cells within the recipient's secondary lymphoid structures. Strategies to improve DC trafficking to these structures may enhance their therapeutic effect.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott</pub><pmid>16477234</pmid><doi>10.1097/01.tp.0000195779.01491.4e</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0041-1337
ispartof Transplantation, 2006-02, Vol.81 (3), p.455-462
issn 0041-1337
1534-6080
language eng
recordid cdi_proquest_miscellaneous_67659038
source MEDLINE; Journals@Ovid Complete
subjects Animals
Biological and medical sciences
Bone Marrow Cells - immunology
Cell Movement - immunology
Dendritic Cells - immunology
Dendritic Cells - transplantation
Fundamental and applied biological sciences. Psychology
Fundamental immunology
Graft Enhancement, Immunologic
Graft Rejection - therapy
Graft Survival - immunology
Isoantigens - immunology
Lymph Nodes - cytology
Male
Medical sciences
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
Skin Transplantation - immunology
Spleen - cytology
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
T-Lymphocytes - immunology
Tissue, organ and graft immunology
Transplantation, Homologous
title Immunosuppressive and trafficking properties of donor splenic and bone marrow dendritic cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T19%3A41%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immunosuppressive%20and%20trafficking%20properties%20of%20donor%20splenic%20and%20bone%20marrow%20dendritic%20cells&rft.jtitle=Transplantation&rft.au=EMMANOUILIDIS,%20Nikos&rft.date=2006-02-15&rft.volume=81&rft.issue=3&rft.spage=455&rft.epage=462&rft.pages=455-462&rft.issn=0041-1337&rft.eissn=1534-6080&rft.coden=TRPLAU&rft_id=info:doi/10.1097/01.tp.0000195779.01491.4e&rft_dat=%3Cproquest_cross%3E67659038%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17092240&rft_id=info:pmid/16477234&rfr_iscdi=true